Zoledronic acid (Reclast)

zoledronic acid · Novartis

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Zoledronic acid (Reclast), covering 2007-08-23 to 2025-12-31. Get the full timeline:

Most recent: Clinical Trial Update: StrAtegies For Zoledronic Acid Post-dEnosumab Discontinuation in Postmenopausal oSTeoporosis [Phase 4]